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Abstract
Hemangiomas are the most common benign tumors of the liver. Most of 
them remain stable. However, when a hemangioma continues to grow, it 
may become symptomatic. We describe a 40-year-old woman who initially 
presented with a hemangioma approximately 3 cm in diameter in the right 
lobe of the liver. Eight years after the initial presentation, the hemangi-
oma had grown to 11 × 8 cm with the symptom of abdominal pain. She 
was managed with conservative treatment at another hospital. However, 
the symptoms and tumor bothered her physically and psychologically for 
1 year. Surgical resection was performed to relieve her symptoms. The 
huge tumor was compressing the inferior vena cava and was very close 
to the middle hepatic vein, which made the operation difficult. The post-
operative course was uneventful. We suggest early surgical resection for 
symptomatic giant hepatic hemangiomas. We also review reports in the 
literature about the treatment of symptomatic hepatic hemangiomas, 
including surgery, transcatheter arterial embolization and radiofrequency 
ablation. [Tzu Chi Med J 2008;20(1):70–72]
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1. Introduction
Although hemangiomas are the most common benign 
tumors of the liver, fewer than 10% of cases undergo 
enlargement [1] and only some of them cause symp-
toms. Intervention is needed in patients with symp-
tomatic hemangiomas. Hemangiomas should not be 
overlooked because they are benign and may need to 
be managed using more than conservative treatment. 
We present a case that was treated using surgery.
2. Case report
A previously healthy 40-year-old woman had a hepa-
tic hemangioma that was incidentally found during 
physical check-up approximately 8 years prior to this 
presentation. The tumor size was about 3–4 cm. Accor-
ding to this patient’s statement, the tumor had con-
tinued to grow about 1 cm in diameter yearly. She did 
not have any discomfort until May 2005 when she felt 
intermittent right upper quadrant abdominal pain 
and right back pain. She also felt fullness and easy 
satiety. The tumor size was approximately 11 × 8 cm. 
She was managed with conservative treatment. How-
ever, the persistent symptoms bothered her physically 
and psychologically for 1 year, and she came to our 
hospital for further management.
On physical examination, her abdomen was mildly 
distended with slight tenderness on the right upper 
quadrant. No edema was found in bilateral lower 
extremities. She was not icteric or pale. Laboratory 
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data revealed that the blood count and liver function 
test results were within reference ranges. Hepatitis B 
virus and hepatitis C virus markers were negative, and 
α-fetoprotein level was 14.56 ng/dL (reference range, 
0–10 ng/dL).
Both computed tomography (Fig. 1) and magnetic 
resonance imaging (Fig. 2) showed that the tumor 
nearly occupied all of segments 7 and 8 and extended 
to segments 5 and 6 with compression on the intra-
hepatic inferior vena cava (IVC) and extended to the 
posterior aspect of the IVC.
Right hepatectomy was performed. A huge reddish 
pink tumor with thin walls was noted. It was highly 
vascular with easy bleeding. Intraoperative ultrasonog-
raphy was used to mark the plane of parenchymal 
transection without injury to the middle hepatic vein. 
Parenchymal transection was performed using an ultra-
sonic dissection device under the Pringle maneuver.
After parenchymal transection and exposure of the 
anteromedial surface of the IVC, the tumor was dis-
sected away from the IVC. Several  short hepatic veins 
were divided. The right hepatic vein was found to be 
directly draining the tumor into the IVC. Finally, we 
divided the draining right hepatic vein between the 
clamps. The tumor measured 11.5 × 8 × 7 cm (Fig. 3). 
Histological examination revealed a cavernous heman-
gioma. The postoperative course was uneventful.
3. Discussion
A giant hemangioma is considered when the size is 
more than 4 cm. Most of them remain stable with 
no symptoms. However, some of them may become 
symptomatic. The most common symptom is abdom-
inal pain or discomfort. For symptomatic patients, it 
is advocated that they undergo thorough evaluations 
to determine any other causes for the symptoms.
Intervention may be needed. In a review of the lit-
erature, occasional case reports of hemangioma rup-
ture either spontaneously or with minimal trauma have 
been reported, especially when the tumor is close 
to the surface. The incidence is about 1–4% and 32 
cases have been described in the literature with a 
high mortality rate (36–69%) [1–3]. In addition, giant 
hemangiomas that extend throughout the entire liver 
or are sequestered and destroy platelets, causing con-
sumptive coagulopathy and symptomatic thrombo-
cytopenia, known as Kasabach-Merritt syndrome that 
require liver transplantation have been reported [4,5].
When considering surgery, it should be emphasized 
that lesion size is not a criterion for resection during 
management of giant liver hemangioma [6]. Patients 
Fig. 1 — Huge mass with peripheral enhanced nodularity 
occupying nearly all of segments 7 and 8 and extending 
to segments 5 and 6. The inferior vena cava is compressed 
to the medial aspect by the mass. The right hepatic vein 
cannot be clearly seen here. The middle hepatic vein is 
very close to the mass (arrow).
Fig. 3 — Cut section of the resected liver: the reddish 
tumor (arrow) measures 11.5 ´  8 ´  7 cm.
Fig. 2 — Magnetic resonance imaging, sagittal view, shows 
the location of the tumor and the inferior vena cava (IVC). 
The tumor is encircling the IVC with extension to the 
posterior aspect of the IVC and near the orifice of the 
hepatic vein.
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who suffer persistent significant symptoms are can-
didates for resection. In the study by Yoon et al, 
among patients with symptoms before resection, 96% 
had resolution of symptoms after their operations 
[7]. Few patients have postoperative wound pain. In 
smaller tumors, enucleation is preferred. However, if 
the tumor precludes safe enucleation, for the patient’s 
safety, anatomic resection is the procedure of choice 
[8]. It should be based on the balance between the 
benefits from surgical resection and the estimated 
operative risks for patients. The operative morbidity 
and mortality rates are low in experienced hands.
In addition to surgical resection, there are other 
modalities (transcatheter arterial embolization [TAE] 
and radiofrequency ablation) available to manage symp-
tomatic hemangioma, especially for high surgical risk 
patients.
There have been several reports from China and 
India that TAE decreases tumor size and results in 
symptom relief. In the report by Zeng et al, in patients 
who underwent TAE, tumor diameters decreased from 
9.7 ± 2.3 cm to 5.6 ± 1.6 cm after TAE treatment [9]. 
The clinical symptoms were relieved in all symptoma-
tic patients. However, transient impairment of liver 
function was noted [9].
In the report by Huang et al, six cases of severe bil-
iary and hepatic complications after hepatic artery em-
bolization for hepatic hemangioma was reported [10].
We have no experience with TAE for hemangiomas 
at our hospital and there is also a limited number of 
reports in the literature in Taiwan. In addition, there 
are no long-term follow-up results of hemangioma size 
after TAE treatment.
Ultrasonography-guided percutaneous radiofre-
quency ablation is another treatment. In the report 
by Cui et al, the ablated lesions shrunk and the range 
was 38–79% [11]. For tumors too close to the hilum 
and the liver borders, care should be taken to avoid 
major complications such as bleeding, biliary compli-
cation and hollow organ perforation.
Symptomatic hemangiomas should not be over-
looked just because they are benign tumors with 
surgical risks for liver operation. We conclude that 
for symptomatic patients, early surgical intervention 
is recommended.
References
 1. Griffa B, Basilico V, Bellotti R, et al. Spontaneous rupture 
of giant subcapsular hemangioma of the liver with hemo-
peritoneum and hemorrhagic shock: a case report. Chir 
Ital 2005;57:389–92.
 2. Corigliano N, Mercantini P, Amodio PM, et al. Hemoperito-
neum from a spontaneous rupture of a giant heman gioma 
of the liver: report of a case. Surg Today 2003;33:459–63.
 3. Cappellani A, Zanghi A, Di Vita M, et al. Spontaneous rup-
ture of a giant hemangioma of the liver. Ann Italy Chir 
2000;71:379–83.
 4. Kumashiro Y, Kasahara M, Nomoto K, et al. Living donor 
liver transplantation for giant hepatic hemangioma with 
Kasabach-Merritt syndrome with a posterior segment 
graft. Liver Transpl 2002;8:721–4.
 5. Ferraz AA, Sette MJ, Maia M, et al. Liver transplant for the 
treatment of giant hepatic hemangioma. Liver Transpl 
2004;10:1436–7.
 6. Terkivatan T, Vrijland WW, Den Hoed PT, et al. Size of 
lesion is not a criterion for resection during management 
of giant liver haemangioma. Br J Surg 2002;89:1240–4.
 7. Yoon SS, Charny CK, Fong Y, et al. Diagnosis, manage-
ment, and outcomes of 115 patients with hepatic heman-
gioma. J Am Coll Surg 2003;197:392–402.
 8. Demircan O, Demiryurek H, Yagmur O. Surgical approach 
to symptomatic giant cavernous hemangioma of the liver. 
Hepatogastroenterology 2005;52:183–6.
 9. Zeng Q, Li Y, Chen Y, et al. Gigantic cavernous heman-
gioma of the liver treated by intra-arterial embolization 
with pingyangmycin-lipiodol emulsion: a multi-center study. 
Cardiovasc Intervent Radiol 2004;27:481–5.
10. Huang XQ, Huang ZQ, Duan WD, et al. Severe biliary 
complications after hepatic artery embolization. World J 
Gastroenterol 2002;8:119–23.
11. Cui Y, Zhou LY, Dong MK, et al. Ultrasonography guided per-
cutaneous radiofrequency ablation for hepatic cavernous 
hemangioma. World J Gastroenterol 2003;9:2132–4.
